To encourage uniformity in the presentation of pharmacokinetic data, a general nomenclature has been developed. The system has wide application. Flexibility is achieved through the use of general variables, constants, qualifying terms, and subscripts. Yet, through the use of impl&d terms, the symbols describing many common variables and constants are simple.
INTRODUCTION
There is a similarity between the present confusion with regard to symbols in pharmacokinetics and the events surrounding the attempt to build the Tower of Babel.
The many symbols used for the same terms in pharmacokinetics by different authors make reading and understanding the literature more 1Editorial comment: Following consultation with the Editors of this Journal the symbols suggested in this article have been adopted as the preferred symbols for use in articles published in the Journal of Pharmacokinetics and Biopharmaceutics. All manuscripts submitted to the Journal should conform to these suggested symbols if possible. The Editors realize, however, that, as the. field develops, certain of the symbols proposed here may become inappropriate and cumbersome. The Editors are thus willing to consider on an individual basis exceptions to the adopted symbology. Requests for exemption should be made by authors in their letter of submittal. These exemptions will then be considered by both the Journal reviewers and the Editors. 29 9 . , , . epartment of Pharmacy, Umverslty of Manchester Manchester M13 9PL England 3University Department of Therapeutics Royal Hallamshire Hospital, Sheffield S10 2JF, England. 4Address correspondence to M.R. difficult than is necessary, for both novice and aficionado alike. A need for uniformity in the use of pharmacokinetic symbols is evident.
The first systematic attempt to achieve this goal of uniformity appears to have occurred during a colloquium on Pharmacokinetics and Drug Dosage, held at the Borstel Institute in Germany, October 25-27, 1962. There, a panel discussion was held with the aim of standardizing terminology in the then newly emerging subject; the term "pharmacokinetics" had been coined by Dost only 9 years previously (1). Not surprisingly, full agreement was not reached at that time. Nonetheless, the outcome was a compilation, albeit limited, of suggested symbols (2) . A perusal of the current literature in pharmacokinetics indicates that, rather than using those symbols recommended in 1962, authors have generally adopted the symbols used in the several books published on the subject between 1966 and 1975 (3-6), or have devised their own sets. Unfortunately, symbols used in the various books, and even within the same book (6), differ.
Recently, a standard set of symbols for terms used to characterize a linear compartmental model has been suggested (7) . We present here a more comprehensive list designed to cover the majority of expressions arising in pharmacokinetics. In doing so, we would like to recommend that these symbols be adopted for use by this Journal and by those engaged in the area. The compilation is by no means exhaustive. Additional terms, and hence symbols, peculiar to specific investigations would, of course, need to be defined clearly as and when they arise.
The approach used here is similar to that adopted in respiratory physiology (8) , namely one which achieves flexibility by dividing the symbols into several categories. Table I contains a list of general variables and constants, together with letters (lowercase) which may be used to qualify them if needed. We have used the symbol A to denote an exponential coefficient and the symbol k to denote a first-order microscopic mass rate constant of a compartmental model Although in the simplest case of a one-compartment linear model A and k are equivalent, we have chosen k to denote the exponential coefficient (elimination rate constant), owing to its common use in pharmacokinetics. Wherever possible, we have also retained symbols which have been widely applied in pharmacokinetics, such as CL for clearance, F for availability, and tl/2 for half-life. Table II contains various subscripts which further qualify the general variables and constants with respect to location, condition, time and route. The implied terms in Table III are intended to overcome the potentially cumbersome nature of the notation when dealing with relatively simple and frequently used expressions. For clarity, all symbols should be italicized both in the equations and in the text.
The application of the suggested notation is illustrated in two ways: by defining commonly used quantities and by writing some representative equations. Table I . General Variables and Constants When the variable AUC is not qualified by an upper and a lower time limit, area between time zero and time infinity is implied When the variable A is not qualified by a lowercase letter, amount of drug in body is implied When the variable CL is not qualified, total clearance of drug is implied The absence of a subscript denoting substance implies that the drug, rather than a metabolite, either is given or is measured When the variable Q is not qualified, blood flow is implied The absence of a specified value for i,/', n, N implies that the respective value is unity The absence of a subscript denoting route of administration implies that the drug is given as an intravenous bolus dose The absence of a subscript implies that this variable is the first-order elimination rate constant of a linear one-compartment model, or the exponential coefficient when disposition is characterized by a monoexponential equation The absence of a subscript denoting the site of measured concentration implies that the site is venous plasma
For any time-dependent variable X, the symbol X implies X(t)
The absence of a lower time limit implies that the variable was measured or calculated from time zero When the variable V is not specified, volume of distribution obtained by dividing the total clearance by the terminal exponential coefficient is implied 
V = CL/Az
where Az is the terminal exponential coefficient.
3. The area subtended by the plasma concentration of the metabolite m2 between times t2 and tl, following an intravenous bolus dose of drug, is given by
where fro2 is the fraction of available drug that is converted to metabolite m2. Note that the total area between time 0 and time oo is denoted simply by AUC (m2). 4. The rate of urinary excretion of a metabolite m2, is related to its plasma concentration by
where CLR (m2) is the renal plasma clearance of the metabolite and C(m2) is its plasma concentration. The cumulative amount of m2 excreted into the urine from time tl to time t2, following oral administration of drug, is
And the corresponding cumulative amount of rn2 excreted from time zero to time infinity is given by
where re(mE) is the fraction of the available metabolite that is excreted unchanged into urine. If metabolite m~ was a precursor of m2, and if m~ instead of drug had been given orally, then the cumulative amount of m2 excreted in urine would be denoted by 
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A2\A1--/I.21 J 3. Rate of elimination from compartment 1 in a two-compartment model when elimination, which occurs exclusively from compartment 1, proceeds by both a first-order process and a saturable process, described by Michaelis-Menten kinetics, is given by where QR is renal blood flow, ER is the renal extraction ratio of drug, and CRA, b,ss, CRV, b,s~ are the concentrations of drug in the renal arterial and venous blood, respectively. 2. Depicting elimination of drug from the liver as occurring from a well-stirred compartment yields the following equation for hepatic blood drug clearance:
where Qn is hepatic blood flow, rUb is the ratio of unbound drug concentration in plasma (Cu) to the total concentration in whole blood, and CLuint is the unbound intrinsic clearance of the drug.
3. The rate of change of drug in blood and all tissues of the body, after an intravenous bolus dose, is defined by where n~ and K~ are the number and the equilibrium constant of the ith set of identical binding sites and Cp is the total protein concentration.
PHARMACOLOGICAL RESPONSE

Intensity of Effect
One equation expressing the relationship between the intensity of response (I) and the concentration of drug at the site of action is
I = ImaxCn/(m + C n)
where/max is the maximum of intensity of effect and m is a constant.
Duration of Effect
When the body acts as a single compartment, the duration of effect, tD, following a single bolus dose is defined by tD = (2.3/k) log (D/Amin) where Amin is the minimum amount of drug in the body needed to produce a predetermined response.
